Contact information
Research groups
Emily Bongard
PhD, MSc, BSc Hons
Head of Operations (PC-CTU)
I have worked directly in clinical trial management for the last 10 years and within the broader scope of clinical trials and infectious disease research over the past 22 years. I have worked on a number of national and international clinical trials in a range of disease areas within primary and secondary care, from Phase I to IV.
As Head of Operations I oversee the day-to-day activities of the CTU, ensuring a robust operational input into all aspects of clinical trial management and delivery. I am responsible for planning, coordinating and managing resource requirements for the trial portfolio deploying staff effectively and efficiently. I work closely with the leadership team to deliver the CTU strategy and with the Head of Administration and Finance to plan the funding and resources of the CTU.
I have a BSc Hons in Biological Sciences from Exeter University, MSc in Clinical Tropical Microbiology from University College London and PhD in Primary Care and Public Health from Cardiff University.
Recent publications
-
Conditional versus non-conditional incentives to maximise return of participant completed questionnaires in clinical trials: a cluster randomised study within a trial
Conference paper
Cook J. et al, (2023), Trials, 24
-
Penicillin allergy status and its effect on antibiotic prescribing, patient outcomes and antimicrobial resistance (ALABAMA): protocol for a multicentre, parallel-arm, open-label, randomised pragmatic trial
Journal article
Armitage KF. et al, (2023), BMJ Open, 13
-
Antibiotics and uncertainty of diagnosis in viral respiratory infections: Point-prevalence survey across 15 European countries
Journal article
Khosravi L. et al, (2023), Acta Paediatrica, International Journal of Paediatrics, 112, 1970 - 1972
-
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries
Journal article
Li X. et al, (2023), European Journal of Health Economics, 24, 909 - 922
-
Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European Countries
Journal article
Vellinga A. et al, (2023), Antibiotics, 12